{
  "meta": {
    "title": "Late_Night_Pyq_Pyt_Medicine-11",
    "url": "https://brainandscalpel.vercel.app/late-night-pyq-pyt-medicine-11-e615b91b.html",
    "scrapedAt": "2025-11-29T18:10:06.731Z"
  },
  "questions": [
    {
      "id": 73089,
      "choices": [
        {
          "id": 291321,
          "text": "<p><span style=\"font-size:12.0pt;\">Muffled heart sounds</span></p>"
        },
        {
          "id": 291322,
          "text": "<p><span style=\"font-size:12.0pt;\">Loud S1</span></p>"
        },
        {
          "id": 291323,
          "text": "<p><span style=\"font-size:12.0pt;\">S3 gallop</span></p>"
        },
        {
          "id": 291324,
          "text": "<p><span style=\"font-size:12.0pt;\">Time interval between S2 and the opening snap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient diagnosed with mitral stenosis is being evaluated. Which clinical finding best indicates the severity of the condition? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q9291949",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833482,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Time interval between S2 and the opening snap</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The <strong>S2-OS (second heart sound to opening snap) interval</strong> is the <strong>best indicator of mitral stenosis severity</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Mild MS:</strong> <strong>S2-OS interval is longer</strong> (~100 ms or more)</span></li><li><span style=\"font-size:16px;\"><strong>Severe MS:</strong> <strong>S2-OS interval is short</strong> (~60 ms or less), indicating <strong>higher left atrial pressure</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>The earlier the opening snap occurs, the more severe the stenosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Muffled heart sounds</strong>: Seen in <strong>pericardial effusion, cardiac tamponade</strong>, not mitral stenosis</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Loud S1:</strong> Common in MS, but <strong>may become soft in severe cases due to valve calcification</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. S3 gallop:</strong> Associated with <strong>heart failure, mitral regurgitation</strong>, not mitral stenosis</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The S2-OS interval is the best clinical indicator of mitral stenosis severity, as a shorter interval reflects higher left atrial pressure and more severe disease progression.</span></p>",
      "correct_choice_id": 291324,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73089/FMGE_Jan_2025_Medicine_Q_-_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73089/FMGE_Jan_2025_Medicine_Q_-_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73086,
      "choices": [
        {
          "id": 291309,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary regurgitation</span></p>"
        },
        {
          "id": 291310,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary embolism</span></p>"
        },
        {
          "id": 291311,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonic stenosis</span></p>"
        },
        {
          "id": 291312,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary arterial hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient reports a gradual increase in breathlessness over the past few months. On physical examination, a prominent left parasternal heave is noted, along with hepatomegaly. Auscultation reveals a loud systolic murmur. What is the most probable diagnosis? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q7405868",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833479,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D)</strong> <strong>Pulmonary arterial hypertension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The key findings strongly suggest <strong>pulmonary hypertension (PAH)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Gradual onset of dyspnea</strong></span></li><li><span style=\"font-size:16px;\"><strong>Left parasternal heave</strong> (<strong>right ventricular hypertrophy</strong>)</span></li><li><span style=\"font-size:16px;\"><strong>Hepatomegaly</strong> (<strong>right heart failure</strong>)</span></li><li><span style=\"font-size:16px;\"><strong>Loud systolic murmur</strong> (<strong>functional tricuspid regurgitation</strong>)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pulmonary regurgitation:</strong> Produces an <strong>early diastolic murmur</strong>, not <strong>systolic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Pulmonary embolism:</strong> Usually <strong>acute onset</strong>, not <strong>gradual progression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Pulmonic stenosis:</strong> Produces an <strong>ejection systolic murmur</strong>, but lacks <strong>right heart failure features</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A triad of chronic dyspnea, left parasternal heave, and hepatomegaly is highly suggestive of pulmonary arterial hypertension.</span></p>",
      "correct_choice_id": 291312,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47535,
      "choices": [
        {
          "id": 189751,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt; 12%</span></p>"
        },
        {
          "id": 189752,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt; 20%</span></p>"
        },
        {
          "id": 189753,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt; 10%</span></p>"
        },
        {
          "id": 189754,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt; 18%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What percentage of increase in FEV1 represents the minimum change required to demonstrate the reversibility of obstruction after administration of bronchodilators in bronchial asthma?</span></p>",
      "unique_key": "Q8944489",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833270,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) &gt; 12%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To diagnose bronchial asthma, it is essential to demonstrate the <strong>reversibility of airway obstruction.</strong> This is typically assessed by measuring the <strong>increase in FEV1</strong> (Forced Expiratory Volume in 1 second) <strong>after the administration of a bronchodilator</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The criteria for significant reversibility in FEV1 are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">An increase in FEV1 of <strong>more than 12%</strong> from the baseline.</span></li><li><span style=\"font-size:12.0pt;\">An absolute increase in FEV1 of <strong>more than 200 ml.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These criteria confirm that the obstruction is reversible, which is a hallmark of asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - </strong>Criterion is used for assessing peak flow rate (PFR) variability is <strong>&gt; 20%</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A minimum increase of more than 12% in FEV1 after bronchodilator administration is required to demonstrate the reversibility of airway obstruction in bronchial asthma.</span></p>",
      "correct_choice_id": 189751,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59290,
      "choices": [
        {
          "id": 236473,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ETCO2</span></span></p>"
        },
        {
          "id": 236474,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood pH</span></span></p>"
        },
        {
          "id": 236475,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood color</span></span></p>"
        },
        {
          "id": 236476,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest X-ray</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is confirmatory to ensure the central line is in the jugular vein? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q8820247",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833268,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Chest X-ray</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chest X-ray is used to confirm the correct placement of a central line. The tip of the central line should be positioned at the junction of the superior vena cava (SVC) and the right atrium, and this can be confirmed only with a chest X-ray.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. ETCO2:</span></strong><span style=\"font-size:12.0pt\"> Used for confirming endotracheal tube placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Blood pH:</span></strong><span style=\"font-size:12.0pt\"> Not specific for central line placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Blood color:</span></strong><span style=\"font-size:12.0pt\"> Can be misleading and is not confirmatory.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chest X-ray is the gold standard for confirming central line placement in the jugular vein.</span></span></span></p>",
      "correct_choice_id": 236476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54286,
      "choices": [
        {
          "id": 216613,
          "text": "<p><span style=\"font-size:12.0pt;\">Allergic Interstitial Nephritis</span></p>"
        },
        {
          "id": 216614,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyelonephritis</span></p>"
        },
        {
          "id": 216615,
          "text": "<p><span style=\"font-size:12.0pt;\">Berger Disease</span></p>"
        },
        {
          "id": 216616,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary Tract Infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old child presented with follicular tonsillitis, for which antibiotics were prescribed. In a few days, the child developed flank pain and rash. Peripheral blood demonstrated eosinophilia, and urinalysis showed WBC casts. What is the likely diagnosis?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3632140",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833258,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Allergic Interstitial Nephritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Allergic interstitial nephritis (AIN), also known as drug-induced interstitial nephritis, is an immune-mediated condition commonly caused by medications such as antibiotics (e.g., penicillins). The clinical presentation of AIN typically includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Recent medication use:</strong> In this case, antibiotics for follicular tonsillitis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Flank pain and rash:</strong> These symptoms often develop a few days after starting the medication.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Eosinophilia:</strong> Elevated levels of eosinophils in peripheral blood are a hallmark of allergic reactions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Urinalysis findings:</strong> Presence of white blood cell (WBC) casts in the urine indicates renal involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The combination of these symptoms and laboratory findings strongly suggests allergic interstitial nephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pyelonephritis:</strong> Pyelonephritis is characterized by fever, unilateral flank pain, and urinary symptoms like dysuria. It is usually associated with bacterial infection, not with recent antibiotic use or eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Berger Disease (IgA Nephropathy):</strong> IgA nephropathy, or Berger disease, is a glomerulonephritis characterized by hematuria and sometimes proteinuria. It does not typically present with rash, eosinophilia, or WBC casts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urinary Tract Infection (UTI):</strong> A UTI would present with urinary symptoms such as dysuria, frequency, and urgency. It can also lead to pyelonephritis, but it does not typically cause eosinophilia or WBC casts in the absence of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Allergic interstitial nephritis is characterized by recent medication use (such as antibiotics), flank pain, rash, eosinophilia, and WBC casts in urine. It is an immune-mediated condition commonly caused by drugs, particularly antibiotics.</span></p>",
      "correct_choice_id": 216613,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54286/INI-CET_May_2024Medicine_Question_31.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54286/INI-CET_May_2024Medicine_Question_31.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47652,
      "choices": [
        {
          "id": 190219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBS</span></span></span></span></p>"
        },
        {
          "id": 190220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FBS</span></span></span></span></p>"
        },
        {
          "id": 190221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PPBS</span></span></span></span></p>"
        },
        {
          "id": 190222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbA1C</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A wife is complaining that her husband is not taking medications for his diabetes regularly and not maintaining his blood glucose for a long time. Which of the following markers is best for long-duration glucose analysis? (</span></span>FMGE Jan 2024</p>",
      "unique_key": "Q4406789",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833275,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) HbA1C</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbA1c, or glycated hemoglobin, is the best marker for assessing long-term glucose control in diabetic patients. It reflects the average blood glucose levels over the past two to three months. This is because glucose binds to hemoglobin in red blood cells, and since red blood cells have a lifespan of about 120 days, the HbA1c value provides a long-term overview of blood glucose levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. RBS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Not suitable for long-term glucose control as it only measures blood sugar at a specific moment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. FBS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Provides fasting glucose levels but does not give a long-term picture.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. PPBS</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Useful for assessing post-meal glucose control but not for long-term analysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbA1c is the best marker for long-term glucose analysis in diabetic patients as it reflects average blood glucose levels over the past two to three months.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The target HbA1c for most patients with diabetes to ensure adequate control is less than 7%, though this may vary based on individual patient circumstances.</span></span></span></span></p>",
      "correct_choice_id": 190222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84311,
      "choices": [
        {
          "id": 335820,
          "text": "<p><span style=\"font-size:12.0pt;\">Etidronate</span></p>"
        },
        {
          "id": 335821,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides</span></p>"
        },
        {
          "id": 335822,
          "text": "<p><span style=\"font-size:12.0pt;\">Elemental calcium</span></p>"
        },
        {
          "id": 335823,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D analogs</span></p>"
        }
      ],
      "text": "<p>Which of the following agents is not typically used in the management of chronic hypocalcemia? (NEET PG 2016)</p>",
      "unique_key": "Q3448327",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833261,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Etidronate.</strong></p><p>&nbsp;</p><p>Etidronate, a bisphosphonate, is not used in treating chronic hypocalcemia. Bisphosphonates are primarily antiresorptive agents that inhibit osteoclast activity and are indicated for conditions like osteoporosis, Paget's disease, and hypercalcemia. In fact, bisphosphonates can worsen hypocalcemia by reducing bone resorption and calcium release from bone, which is counterproductive in chronic hypocalcemic states.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Thiazides</strong>: This is incorrect because thiazides are actually used in chronic hypocalcemia management. Thiazides reduce urinary calcium excretion (↓Uca) and help increase serum calcium levels (↑S.ca), making them beneficial in hypocalcemic states.</p><p>&nbsp;</p><p><strong>Option C. Elemental calcium</strong>: This is incorrect because calcium supplementation is the cornerstone of managing chronic hypocalcemia. Oral calcium (carbonate or citrate) is a fundamental component in the treatment regimen for patients with persistent hypocalcemia.</p><p>&nbsp;</p><p><strong>Option D. Vitamin D analogs</strong>: This is incorrect because vitamin D analogs, particularly calcitriol (1,25-dihydroxyvitamin D), are essential in hypocalcemia management. Calcitriol enhances intestinal calcium absorption and is typically administered alongside calcium supplements.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>The management of chronic hypocalcemia centers on calcium replacement (oral calcium), optimization of intestinal calcium absorption (vitamin D analogs/calcitriol), and reduction of urinary calcium excretion (thiazides), while bisphosphonates are contraindicated as they can worsen hypocalcemia.</p>",
      "correct_choice_id": 335820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47649,
      "choices": [
        {
          "id": 190207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5-0.8</span></span></span></span></p>"
        },
        {
          "id": 190208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1.5</span></span></span></span></p>"
        },
        {
          "id": 190209,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1.5-2</span></span></span></span></p>"
        },
        {
          "id": 190210,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-3</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 43-year-old patient with a history of mitral valve replacement on anticoagulation with warfarin is about to undergo hernioplasty for inguinal hernia. What is the target INR prior to surgery? (</span></span>FMGE Jan 2024)</p>",
      "unique_key": "Q5850140",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833272,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1.5</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prior to any major surgery, including abdominal surgeries like hernioplasty, it is crucial to manage the patient&#39;s anticoagulation status to minimize the risk of excessive bleeding. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For patients on warfarin, the target INR should be brought to less than 1.5 before the surgery. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This can be achieved by stopping warfarin and administering vitamin K if necessary. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the INR remains above 1.5 on the day of surgery, fresh frozen plasma (FFP) may be administered to rapidly lower the INR. This approach balances the need to prevent excessive bleeding during surgery while managing the risk of thromboembolic complications.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 0.5-0.8</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This range is too low for general surgical preparation and would indicate a significant reversal of anticoagulation, which is not typically required.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 1.5-2</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While this range might be acceptable for some minor procedures, major surgeries generally require an INR of less than 1.5 to ensure safety.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 2-3</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This range is appropriate for therapeutic anticoagulation but is too high for surgical procedures due to the increased risk of bleeding.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For patients on warfarin undergoing major surgery, the target INR should be less than 1.5 to minimize bleeding risk.</span></span></span></span></p>",
      "correct_choice_id": 190208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54294,
      "choices": [
        {
          "id": 216645,
          "text": "<p><span style=\"font-size:12.0pt;\">Occur in the early 20s, rare after 40</span></p>"
        },
        {
          "id": 216646,
          "text": "<p><span style=\"font-size:12.0pt;\">More common in males than females</span></p>"
        },
        {
          "id": 216647,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA B27 is positive in &gt;90%</span></p>"
        },
        {
          "id": 216648,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI shows non-erosive joint widening</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements regarding Ankylosing Spondylitis are true except:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3620221",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833256,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) MRI shows non-erosive joint widening</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MRI shows non-erosive joint widening</strong>: This is false. In ankylosing spondylitis, MRI typically shows evidence <strong>of erosions, joint narrowing, and inflammatory changes</strong> in the sacroiliac joints and spine. The disease can lead to ankylosis (fusion of the spine), syndesmophytes, and erosive arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints. The correct statements regarding AS are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Occur in the early 20s, rare after 40</strong>: Ankylosing spondylitis typically presents in young adults, often in their 20s, and is uncommon after the age of 40.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. More common in males than females</strong>: AS is more prevalent in males, with a male-to-female ratio of approximately 3:1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HLA B27 is positive in &gt;90%</strong>: Over 90% of patients with AS test positive for the HLA-B27 gene, which is a significant marker for the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MRI findings in ankylosing spondylitis typically show erosive changes and joint narrowing, not non-erosive joint widening.</span></p>",
      "correct_choice_id": 216648,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54294/INI-CET_May_2024Medicine_Question_39.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54294/INI-CET_May_2024Medicine_Question_39.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55410,
      "choices": [
        {
          "id": 221101,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Breast</span></span></p>"
        },
        {
          "id": 221102,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cervix</span></span></p>"
        },
        {
          "id": 221103,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ovary</span></span></p>"
        },
        {
          "id": 221104,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometrium</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Most common cancer in India in females is: (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q3982820",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833278,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Breast</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In India, breast cancer is the most common cancer among females. It has surpassed cervical cancer, which previously held the top position. Breast cancer has a high incidence due to various factors, including genetic predisposition, lifestyle changes, and increased awareness leading to higher detection rates. Early detection through screening programs, such as mammography, plays a crucial role in managing and reducing the mortality associated with breast cancer.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Cervix:</strong> Cervical cancer is the second most common cancer among women in India. It is caused primarily by persistent infection with high-risk human papillomavirus (HPV) types. Despite its high incidence, it is not as common as breast cancer.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Ovary:</strong> Ovarian cancer is less common compared to breast and cervical cancers. It often presents at a later stage due to nonspecific symptoms, making it a significant cause of gynecologic cancer mortality.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Endometrium:</strong> Endometrial cancer is also less common than breast and cervical cancers in India. It typically occurs in postmenopausal women and is often associated with hormonal imbalances.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Breast cancer is the most common cancer among females in India, highlighting the importance of regular screening and early detection to improve outcomes.</span></span></p>",
      "correct_choice_id": 221101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55419,
      "choices": [
        {
          "id": 221137,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iron deficiency anemia</span></span></p>"
        },
        {
          "id": 221138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anemia of chronic disease</span></span></p>"
        },
        {
          "id": 221139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aplastic anemia</span></span></p>"
        },
        {
          "id": 221140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myelodysplastic syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 65-year-old female presented with anemia. What is the most common cause? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q6158784",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833493,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Iron deficiency anemia</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iron deficiency anemia is the most common cause of anemia across all age groups, including older adults. It occurs when the body&#39;s iron stores are depleted, leading to reduced production of hemoglobin and red blood cells. This condition is especially common in older adults due to factors such as poor dietary intake, gastrointestinal bleeding, and malabsorption.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In elderly patients, it is crucial to rule out underlying causes of iron deficiency anemia, particularly gastrointestinal malignancies such as colorectal cancer. For postmenopausal women and elderly men presenting with anemia, investigations such as colonoscopy or fecal occult blood tests are important to identify or exclude potential sources of chronic blood loss.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Anemia of chronic disease</strong>: This type of anemia is common in patients with chronic infections, inflammatory diseases, or malignancies, but it is not the most common cause of anemia in the general elderly population.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Aplastic anemia: </strong>&nbsp;A rare condition characterized by pancytopenia and bone marrow failure. It is not a common cause of anemia in the elderly.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Myelodysplastic syndrome: </strong>&nbsp;A group of disorders caused by poorly formed or dysfunctional blood cells, more common in older adults, but not as prevalent as iron deficiency anemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iron deficiency anemia is the most common cause of anemia, especially in elderly patients, and requires thorough evaluation to rule out serious underlying conditions such as gastrointestinal malignancies.</span></span></p>",
      "correct_choice_id": 221137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84319,
      "choices": [
        {
          "id": 335852,
          "text": "<p>Parietal lobe</p>"
        },
        {
          "id": 335853,
          "text": "<p>Frontal lobe</p>"
        },
        {
          "id": 335854,
          "text": "<p>Occipito-temporal</p>"
        },
        {
          "id": 335855,
          "text": "<p>Parieto-occipital</p>"
        }
      ],
      "text": "<p>Which brain region's lesion leads to prosopagnosia?(NEET PG 2017)</p>",
      "unique_key": "Q5985590",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833263,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) Occipito-temporal</strong></p><p>&nbsp;</p><p>Prosopagnosia is the inability to recognize faces, which results from lesions in the occipito-temporal cortex, specifically the fusiform face area. This region is specialized for facial recognition and processing. The right hemisphere's fusiform gyrus is particularly critical for this function. When damaged, patients can still see faces normally but cannot identify them as familiar - they may even fail to recognize their own face in a mirror, despite having intact visual perception of other objects.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Parietal lobe</strong> - Lesions here typically cause deficits like hemineglect (right parietal), Gerstmann syndrome (left angular gyrus with agraphia, acalculia, finger agnosia, right-left confusion), or constructional/dressing apraxia, not prosopagnosia.</p><p>&nbsp;</p><p><strong>Option B. Frontal lobe</strong> - Damage causes executive dysfunction, personality changes, motor deficits, and Broca's aphasia when in the dominant hemisphere. Face recognition remains intact.</p><p>&nbsp;</p><p><strong>Option D. Parieto-occipital</strong> - While this region is involved in complex visual processing, lesions here typically cause visual spatial deficits like Balint's syndrome rather than specific face recognition problems.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Prosopagnosia results from damage to specialized face-processing regions in the occipito-temporal cortex (fusiform face area), typically following right posterior cerebral artery territory infarcts.</p>",
      "correct_choice_id": 335854,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47650,
      "choices": [
        {
          "id": 190211,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron Deficiency Anemia</span></p>"
        },
        {
          "id": 190212,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic Anemia</span></p>"
        },
        {
          "id": 190213,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia of Chronic Disease</span></p>"
        },
        {
          "id": 190214,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic Anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with fatigue and pallor. Investigations show Hb = 5.8 gm/dl, low ferritin, high TIBC, low MCV, high RDW. Diagnosis is? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q9496303",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833273,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Iron Deficiency Anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is characterized by low hemoglobin levels, low ferritin (indicating depleted iron stores), high total iron-binding capacity (TIBC), low mean corpuscular volume (MCV), and high red cell distribution width (RDW). These laboratory findings are classic for iron deficiency anemia:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Low ferritin&nbsp;</strong>indicates depleted iron stores.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High TIBC&nbsp;</strong>reflects an increase in the body's attempt to capture more iron due to deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low MCV&nbsp;</strong>signifies microcytic anemia, common in iron deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High RDW&nbsp;</strong>indicates variability in red cell size, often seen in iron deficiency as the body produces new, smaller red cells alongside older, larger ones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Megaloblastic Anemia</strong>: Typically presents with high MCV (macrocytic anemia) due to deficiency of vitamin B12 or folate, not low MCV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anemia of Chronic Disease</strong>: Often presents with normal or high ferritin (reflecting inflammation or infection) and low TIBC, not high TIBC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sideroblastic Anemia</strong>: Generally associated with increased iron stores, not low ferritin, and may show a dimorphic blood picture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is indicated by low hemoglobin, low ferritin, high TIBC, low MCV, and high RDW.</span></p>",
      "correct_choice_id": 190211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76031,
      "choices": [
        {
          "id": 303001,
          "text": "<p><span style=\"font-size:16px;\">Reverses atelectasis and prevents collapse</span></p>"
        },
        {
          "id": 303002,
          "text": "<p><span style=\"font-size:16px;\">Increases CO2 elimination</span></p>"
        },
        {
          "id": 303003,
          "text": "<p><span style=\"font-size:16px;\">Increases work of breathing</span></p>"
        },
        {
          "id": 303004,
          "text": "<p><span style=\"font-size:16px;\">Decreases end expiratory pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient underwent a major 14-hour-long surgery in the prone position and continues to be on a ventilator during recovery. What is the advantage of Positive End Expiratory Pressure (PEEP) in mechanical ventilation?&nbsp;</span></p>",
      "unique_key": "Q4968021",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833484,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Reverses atelectasis and prevents collapse</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Positive End Expiratory Pressure (PEEP) is used in mechanical ventilation primarily to keep the alveoli in a partially open state at the end of expiration. This partial inflation increases the Functional Residual Capacity (FRC) of the lungs, which enhances oxygenation and gas exchange. The advantage of keeping alveoli in a partially open state is similar to inflating a partially filled balloon compared to a completely collapsed one; it is much easier to expand a partially filled balloon than one that is fully deflated. This mechanism reduces the work of breathing and prevents the alveoli from completely collapsing, which helps maintain consistent gas exchange and reduces lung trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Increases CO2 elimination:</strong> This is incorrect because PEEP primarily increases oxygenation by preventing alveolar collapse rather than specifically enhancing CO2 elimination.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Increases work of breathing:</strong> This is incorrect. PEEP actually reduces the work of breathing by keeping the alveoli partially open, which makes lung inflation easier.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Decreases end expiratory pressure:</strong> This is incorrect because PEEP, by definition, increases end-expiratory pressure to prevent alveolar collapse, not decrease it.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The main advantage of PEEP in mechanical ventilation is that it helps reverse atelectasis and prevents alveolar collapse, improving oxygenation and reducing the work of breathing.</span></p>",
      "correct_choice_id": 303001,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/76031/Neet_Pg_Aug_2024_Medicine_Q_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/76031/Neet_Pg_Aug_2024_Medicine_Q_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55409,
      "choices": [
        {
          "id": 221097,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gilbert syndrome</span></span></p>"
        },
        {
          "id": 221098,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rotor syndrome</span></span></p>"
        },
        {
          "id": 221099,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dubin Johnson syndrome</span></span></p>"
        },
        {
          "id": 221100,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Primary biliary cholangitis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following causes unconjugated hyperbilirubinemia? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q7210111",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833277,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Gilbert syndrome</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gilbert syndrome is a common hereditary condition characterized by mild unconjugated hyperbilirubinemia. This condition arises due to a partial deficiency of the enzyme UDP-glucuronosyltransferase, which is responsible for conjugating bilirubin in the liver. As a result, there is an accumulation of unconjugated (indirect) bilirubin in the bloodstream. Patients with Gilbert syndrome often have normal liver function tests and no significant liver pathology.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Rotor syndrome</strong>: &nbsp;This is a rare hereditary condition that causes conjugated (direct) hyperbilirubinemia due to defects in hepatic storage and excretion of conjugated bilirubin.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Dubin Johnson syndrome: </strong>Another hereditary condition that leads to conjugated hyperbilirubinemia, characterized by a defect in the excretion of conjugated bilirubin into the bile ducts. The liver cells appear darkly pigmented due to the accumulation of a pigment similar to melanin.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D</strong>. <strong>Primary biliary cholangitis: </strong>This is an autoimmune disease that causes destruction of the small bile ducts in the liver, leading to cholestasis and conjugated hyperbilirubinemia. It is associated with elevated alkaline phosphatase levels and the presence of antimitochondrial antibodies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gilbert syndrome causes unconjugated hyperbilirubinemia due to a partial deficiency of the enzyme UDP-glucuronosyltransferase, whereas Rotor syndrome, Dubin Johnson syndrome, and primary biliary cholangitis cause conjugated hyperbilirubinemia.</span></span></p>",
      "correct_choice_id": 221097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55418,
      "choices": [
        {
          "id": 221133,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Prednisolone</span></span></p>"
        },
        {
          "id": 221134,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Imatinib</span></span></p>"
        },
        {
          "id": 221135,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cyclophosphamide</span></span></p>"
        },
        {
          "id": 221136,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Indomethacin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What is the neoadjuvant therapy used for GIST? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q4936141",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833492,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Imatinib</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gastrointestinal stromal tumors (GISTs) are most commonly associated with mutations in the KIT gene or PDGFRA gene. Imatinib, a tyrosine kinase inhibitor, is used as neoadjuvant therapy for GISTs to shrink the tumor before surgery. This is particularly effective in GISTs with KIT mutations and some PDGFRA mutations.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">However, not all GISTs respond to imatinib. For instance, GISTs with the PDGFRA D842V mutation or those classified as &quot;wild-type&quot; (lacking KIT or PDGFRA mutations) do not respond well to imatinib. In such cases, surgery is considered the primary treatment option.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Prednisolone: </strong>Prednisolone is a corticosteroid used in various inflammatory and autoimmune conditions but not typically used for GISTs.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Cyclophosphamide: </strong>Cyclophosphamide is an alkylating agent used in certain cancers and autoimmune conditions, but it is not used for GISTs.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Indomethacin: &nbsp;</strong>Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation but has no role in the treatment of GISTs.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Imatinib is the preferred neoadjuvant therapy for GISTs with KIT or certain PDGFRA mutations to reduce tumor size before surgery. It is not effective for all GISTs, particularly those with specific mutations such as PDGFRA D842V or &quot;wild-type&quot; GISTs.</span></span></p>",
      "correct_choice_id": 221134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55415,
      "choices": [
        {
          "id": 221121,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It inhibits dihydrofolate reductase</span></span></p>"
        },
        {
          "id": 221122,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It acts as an alkylating agent</span></span></p>"
        },
        {
          "id": 221123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It inhibits topoisomerase II</span></span></p>"
        },
        {
          "id": 221124,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It inhibits polymerization of tubulin monomers in mitosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What is the mechanism of action of methotrexate in the treatment of cancer? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q9515878",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833283,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) It inhibits dihydrofolate reductase</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate is an antimetabolite and antifolate drug used in the treatment of various types of cancer. Its primary mechanism of action is the inhibition of the enzyme dihydrofolate reductase (DHFR). DHFR is crucial for the synthesis of tetrahydrofolate, which is necessary for the synthesis of purines and thymidylate, essential components of DNA. By inhibiting DHFR, methotrexate leads to the depletion of tetrahydrofolate and ultimately inhibits DNA synthesis, cell replication, and cell function, which is particularly effective against rapidly dividing cancer cells.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Acts as an alkylating agent:</strong> Alkylating agents work by adding an alkyl group to the DNA molecule, which can lead to DNA strand breaks and cell death. Methotrexate does not work by this mechanism.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Inhibits topoisomerase II:</strong> Topoisomerase II inhibitors prevent the DNA from uncoiling and duplicating. Drugs like etoposide and doxorubicin work by this mechanism.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Inhibits polymerization of tubulin monomers in mitosis:</strong> This is the mechanism of action of drugs like vincristine and paclitaxel, which interfere with microtubule formation and function.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate exerts its anticancer effects primarily by inhibiting the enzyme dihydrofolate reductase, thereby blocking the synthesis of DNA and RNA necessary for cell replication.</span></span></p>",
      "correct_choice_id": 221121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52316,
      "choices": [
        {
          "id": 208761,
          "text": "<p><span style=\"font-size:12.0pt;\">Disseminated TB</span></p>"
        },
        {
          "id": 208762,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic Acquired Aplastic Anemia</span></p>"
        },
        {
          "id": 208763,
          "text": "<p><span style=\"font-size:12.0pt;\">Paroxysmal Nocturnal Hemoglobinuria</span></p>"
        },
        {
          "id": 208764,
          "text": "<p><span style=\"font-size:12.0pt;\">Myelodysplastic Syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old boy presented with gum bleeding, easy bruising, and fatigue. He was suffering from fever for 1 month and on examination, he had pallor and a petechial rash distributed all over the body. His peripheral smear revealed macrocytes and his corrected reticulocyte count was 0.5%. Bone marrow revealed few fatty streaks, no immature cells, and no inflammatory cells. What should be the likely diagnosis?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q6004780",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833265,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Idiopathic Acquired Aplastic Anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation of gum bleeding, easy bruising, fatigue, fever, pallor, and petechial rash suggests <strong>Pancytopenia</strong>. Pancytopenia can result from several conditions, but the key clues here are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Bone marrow findings:</strong> The bone marrow shows few fatty streaks, no immature cells, and no inflammatory cells, indicating a hypocellular marrow.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Corrected reticulocyte count:</strong> A low corrected reticulocyte count (0.5%) indicates poor bone marrow response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These findings are characteristic of idiopathic acquired aplastic anemia, a condition where the bone marrow fails to produce adequate amounts of blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Disseminated TB:</strong> Disseminated TB usually presents with systemic symptoms and may show a cellular bone marrow due to granulomas and other inflammatory changes, which is not consistent with the findings of a hypocellular marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Paroxysmal Nocturnal Hemoglobinuria (PNH):</strong> PNH typically presents with hemolytic anemia, thrombosis, and sometimes pancytopenia. However, it usually shows a cellular marrow unless it is associated with aplastic anemia. In exams, PNH is generally considered a cause of cellular marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Myelodysplastic Syndrome (MDS):</strong> MDS usually presents with a hypercellular or normocellular marrow with dysplastic changes. It can cause pancytopenia, but the marrow is typically not hypocellular except in rare cases of hypoplastic MDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Idiopathic acquired aplastic anemia should be considered in patients presenting with pancytopenia, bleeding, bruising, fatigue, and hypocellular bone marrow without significant inflammatory or immature cells. The diagnosis is supported by a low corrected reticulocyte count and clinical findings consistent with bone marrow failure.</span></p>",
      "correct_choice_id": 208762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47659,
      "choices": [
        {
          "id": 190247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycobacterium tuberculosis (MTB)</span></span></span></span></p>"
        },
        {
          "id": 190248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MTB + Rifampicin resistance</span></span></span></span></p>"
        },
        {
          "id": 190249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MTB + Isoniazid resistance</span></span></span></span></p>"
        },
        {
          "id": 190250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MTB + Ethambutol and Rifampicin</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with suspected tuberculosis underwent CBNAAT testing and is started on HRZE. CBNAAT is helpful for which of the following?</span></span></p>",
      "unique_key": "Q1404576",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833487,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) MTB + Rifampicin resistance</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cartridge-based nucleic acid amplification test (CBNAAT) is a rapid molecular test for the detection of Mycobacterium tuberculosis (MTB) and resistance to rifampicin (RIF).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is highly effective for diagnosing tuberculosis and determining rifampicin resistance by detecting mutations in the <strong>rpoB gene</strong>, which is associated with rifampicin resistance. This allows for quick initiation of appropriate therapy, especially important in cases of drug-resistant TB</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MTB Detection</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: CBNAAT can confirm the presence of Mycobacterium tuberculosis.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin Resistance</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: By identifying rpoB gene mutations, CBNAAT can detect rifampicin resistance, which is a critical factor in managing and treating TB.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mycobacterium tuberculosis (MTB)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While CBNAAT detects MTB, it also provides crucial information about rifampicin resistance, making option B more accurate.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. MTB + Isoniazid resistance</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: CBNAAT does not detect isoniazid resistance directly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. MTB + Ethambutol and Rifampicin</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: CBNAAT does not provide information about ethambutol resistance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CBNAAT is a rapid and effective test for detecting Mycobacterium tuberculosis and rifampicin resistance by identifying mutations in the rpoB gene.</span></span></span></span></p>",
      "correct_choice_id": 190248,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47665,
      "choices": [
        {
          "id": 190271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5-1&deg;C per hour</span></span></span></span></p>"
        },
        {
          "id": 190272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5-1&deg;C per 2 hours</span></span></span></span></p>"
        },
        {
          "id": 190273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5-2&deg;C per hour</span></span></span></span></p>"
        },
        {
          "id": 190274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5-2&deg;C per 4 hours</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In primary accidental hypothermia, what is the usual rate of rewarming with passive<strong> </strong>external rewarming?</span></span></p>",
      "unique_key": "Q2585301",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833489,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 0.5-2&deg;C per hour</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary accidental hypothermia refers to an unintentional drop in core body temperature due to environmental exposure. The management of hypothermia includes rewarming strategies, which can be classified into passive and active rewarming.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Passive External Rewarming</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This method involves insulating the patient by covering them with blankets and ensuring that the head is also covered. It relies on the patient&#39;s own heat production to gradually increase body temperature.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to standard medical guidelines and Harrison&#39;s principles, passive external rewarming can increase the core body temperature by approximately 0.5 to 2&deg;C per hour.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of primary accidental hypothermia, passive external rewarming can raise the core body temperature by 0.5 to 2&deg;C per hour.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Information &ndash; </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothermia based on core body temperature and corresponding treatment methods:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild Hypothermia</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Core Body Temperature</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Less than 35 degrees Celsius.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Passive external rewarming is the treatment of choice.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderate Hypothermia</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Core Body Temperature</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Less than 32 degrees Celsius.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Requires both passive and active rewarming methods. Passive rewarming involves external methods, while active rewarming can be either external or internal.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe Hypothermia</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Core Body Temperature</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Less than 28 degrees Celsius.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Requires both passive and active rewarming methods. Passive rewarming involves external methods, while active rewarming can be either external or internal.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>",
      "correct_choice_id": 190273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74907,
      "choices": [
        {
          "id": 298525,
          "text": "<p><span style=\"font-size:16px;\">HLA B8</span></p>"
        },
        {
          "id": 298526,
          "text": "<p><span style=\"font-size:16px;\">HLA B27</span></p>"
        },
        {
          "id": 298527,
          "text": "<p><span style=\"font-size:16px;\">HLA B5</span></p>"
        },
        {
          "id": 298528,
          "text": "<p><span style=\"font-size:16px;\">HLA B51</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with uveitis and sacroiliitis. What is most likely associated with it? (INICET NOV 2024)</span></p>",
      "unique_key": "Q5045713",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833252,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) HLA B27</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The presentation of uveitis along with sacroiliitis is a classic manifestation of seronegative spondyloarthropathy, which is strongly associated with HLA-B27. These conditions are characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Inflammatory back pain</span></li><li><span style=\"font-size:16px;\">Early morning stiffness lasting more than one hour</span></li><li><span style=\"font-size:16px;\">Pain and stiffness that improve with exercise and worsen with rest</span></li><li><span style=\"font-size:16px;\">Anterior uveitis as the most common extra-articular manifestation</span></li><li><span style=\"font-size:16px;\">Sacroiliitis</span></li><li><span style=\"font-size:16px;\">Peripheral arthritis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. HLA B8:</strong> Incorrect. Associated with good prognosis in sarcoidosis, not spondyloarthropathy</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. HLA B5:</strong> Incorrect. Associated with Behçet's disease</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. HLA B51:</strong> Incorrect. Also associated with Behçet's disease</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">HLA-B27 is strongly associated with seronegative spondyloarthropathies, particularly when patients present with the combination of uveitis and sacroiliitis.</span></p>",
      "correct_choice_id": 298526,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74907/INI-CET_NOV_2024_Medicine_Q_-_32.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74907/INI-CET_NOV_2024_Medicine_Q_-_32.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84310,
      "choices": [
        {
          "id": 335816,
          "text": "<p><span style=\"font-size:12.0pt;\">0.04 mIU/L</span></p>"
        },
        {
          "id": 335817,
          "text": "<p><span style=\"font-size:12.0pt;\">0.1 mIU/L</span></p>"
        },
        {
          "id": 335818,
          "text": "<p><span style=\"font-size:12.0pt;\">0.004 mIU/L</span></p>"
        },
        {
          "id": 335819,
          "text": "<p><span style=\"font-size:12.0pt;\">0.0044 mIU/L</span></p>"
        }
      ],
      "text": "<p>What is the lowest detection limit for third-generation TSH assays? (NEET PG 2016)</p>",
      "unique_key": "Q6284334",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833260,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) 0.004 mIU/L</strong></p><p>&nbsp;</p><p>The third-generation TSH immunochemiluminometric assays (ICMAs) have extremely high sensitivity, capable of detecting very low TSH levels. Extremely sensitive assays can detect TSH levels ≤0.004 mIU/L, though for practical clinical purposes, assays sensitive to ≤0.1 mIU/L are generally sufficient. This high sensitivity is what allows these modern assays to discriminate between the lower limit of the normal range and the suppressed values seen in thyrotoxicosis.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. 0.04 mIU/L</strong>: This value is incorrect as it is 10 times higher than the actual detection limit of third-generation TSH assays, which can detect levels down to 0.004 mIU/L.</p><p>&nbsp;</p><p><strong>Option B. 0.1 mIU/L</strong>: This represents the practical sensitivity threshold that is considered sufficient for most clinical purposes, but is not the actual detection limit of third-generation assays.</p><p>&nbsp;</p><p><strong>Option D. 0.0044 mIU/L</strong>: This value is incorrect. The detection limit for extremely sensitive third-generation TSH assays is 0.004 mIU/L.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Third-generation TSH immunochemiluminometric assays can detect TSH levels as low as 0.004 mIU/L, which is essential for discriminating between the lower limit of the normal reference range and the suppressed values found in thyrotoxicosis, though for most clinical applications, assays with sensitivity to 0.1 mIU/L are adequate.</p>",
      "correct_choice_id": 335818,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16185,
      "choices": [
        {
          "id": 64700,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CT pulmonary angiogram</span></span></span></p>"
        },
        {
          "id": 64701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ECG</span></span></span></p>"
        },
        {
          "id": 64702,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CT thorax</span></span></span></p>"
        },
        {
          "id": 64703,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Echocardiography</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An elderly male on bed rest for many months presented with breathlessness and chest pain. What is the next best step in the management of this patient?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q7012004",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833269,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) CT pulmonary angiogram</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient has a history of prolonged immobilization and presents with symptoms of breathlessness and pleuritic chest pain, which are suggestive of pulmonary embolism (PE). Prolonged bed rest is a significant risk factor for PE due to venous stasis and the potential for deep vein thrombosis (DVT) to embolize to the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A <strong>CT pulmonary angiogram is the gold standard diagnostic test</strong> <strong>for acute pulmonary embolism</strong>. It provides a detailed image of the pulmonary arteries and can identify the presence of emboli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Screening test &ndash; D-dimer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. ECG:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While an ECG can be performed to check for any cardiac abnormalities, the most common finding in PE is sinus tachycardia, which is not specific. It will not confirm the diagnosis of PE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. CT thorax:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A CT thorax without angiogram will not provide the necessary details to diagnose PE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Echocardiography:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Echocardiography can show right ventricular dysfunction, which may suggest PE, but it is not definitive for diagnosing PE. It is more useful for assessing the cardiac impact of an established PE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The CT pulmonary angiogram is the gold standard investigation for confirming pulmonary embolism.</span></span></span></p>",
      "correct_choice_id": 64700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55414,
      "choices": [
        {
          "id": 221117,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cyclophosphamide</span></span></p>"
        },
        {
          "id": 221118,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bleomycin</span></span></p>"
        },
        {
          "id": 221119,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Paclitaxel</span></span></p>"
        },
        {
          "id": 221120,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Capecitabine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following drugs used for cancers can cause hand-foot syndrome? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q5406918",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833282,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D) Capecitabine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hand-foot syndrome, also known as palmar-plantar erythrodysesthesia, is a side effect of certain chemotherapy drugs. It is characterized by redness, swelling, and pain on the palms of the hands and soles of the feet. This condition is most commonly associated with pyrimidine analogs, such as 5-fluorouracil (5-FU) and its prodrug capecitabine. Capecitabine is a widely used chemotherapeutic agent for various cancers, including colorectal and breast cancer, and is well known for causing hand-foot syndrome as a dose-limiting toxicity.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Cyclophosphamide</strong>: &nbsp;This is an alkylating agent used in cancer treatment and does not typically cause hand-foot syndrome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Bleomycin: </strong>&nbsp;An antitumor antibiotic used in cancer therapy, primarily associated with pulmonary toxicity rather than hand-foot syndrome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Paclitaxel: </strong>A microtubule inhibitor used in cancer treatment, which can cause peripheral neuropathy and hypersensitivity reactions, but is not commonly associated with hand-foot syndrome.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Capecitabine, a pyrimidine analog, is the cancer drug most commonly associated with causing hand-foot syndrome, characterized by redness, swelling, and pain in the hands and feet.</span></span></p>",
      "correct_choice_id": 221120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52317,
      "choices": [
        {
          "id": 208765,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt Lymphoma</span></p>"
        },
        {
          "id": 208766,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin Lymphoma</span></p>"
        },
        {
          "id": 208767,
          "text": "<p><span style=\"font-size:12.0pt;\">Mantle Cell Lymphoma</span></p>"
        },
        {
          "id": 208768,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular Lymphoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old lady presented with generalized fatigue and lethargy. Her general examination revealed a few superficial lymph nodes in the cervical and axillary regions. Labs – TC: 7400, Hb: 12.8 g/dL, and Platelets: 244,000. She had a normal DC and lymph node biopsy revealed architectural distortion, infiltration with cells with indented nucleus, and prominent nucleolus containing atypical cells. Immunophenotyping showed CD10 and Bcl2 were positive. What is the likely diagnosis?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q3175439",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833266,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Follicular Lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of follicular lymphoma is supported by several key features in this patient's presentation and pathology findings:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Architectural distortion and infiltration with atypical cells:</strong> These findings on lymph node biopsy are consistent with follicular lymphoma.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Immunophenotyping:</strong> The presence of CD10 and Bcl2 positivity is characteristic of follicular lymphoma. CD10 is a marker indicating origin from the germinal center, and Bcl2 positivity suggests the presence of the anti-apoptotic protein Bcl2, which is a hallmark of follicular lymphoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Burkitt Lymphoma:</strong> Burkitt lymphoma is associated with <strong>c-myc</strong> overexpression due to the t(8;14) translocation. It often presents with a high proliferation index and does not typically express Bcl2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hodgkin Lymphoma:</strong> Hodgkin lymphoma is characterized by the <strong>presence of Reed-Sternberg cells</strong>. Sometime, PD1 overexpression. Immunophenotyping usually shows CD15 and CD30 positivity, not CD10 and Bcl2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mantle Cell Lymphoma:</strong> Mantle cell lymphoma is characterized by cyclin D1 overexpression due to the t(11;14) translocation. It is usually CD5 and cyclin D1 positive, not CD10 and Bcl2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Follicular lymphoma often presents with lymphadenopathy and generalized symptoms such as fatigue. Key diagnostic features include CD10 and Bcl2 positivity on immunophenotyping, reflecting its germinal center origin and overexpression of the anti-apoptotic protein Bcl2.</span></p>",
      "correct_choice_id": 208768,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55413,
      "choices": [
        {
          "id": 221113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anemia</span></span></p>"
        },
        {
          "id": 221114,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Preeclampsia</span></span></p>"
        },
        {
          "id": 221115,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Neural tube defects</span></span></p>"
        },
        {
          "id": 221116,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gestational diabetes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following can be prevented by folic acid supplementation in pregnancy? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q5083754",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833281,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Neural tube defects</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Folic acid supplementation before conception and during early pregnancy significantly reduces the risk of neural tube defects (NTDs) in the developing fetus. Neural tube defects are serious birth defects of the brain and spine, such as spina bifida and anencephaly. Adequate folic acid intake is crucial during the early stages of pregnancy, often before a woman even knows she is pregnant, which is why supplementation is recommended for all women of childbearing age.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Anemia: </strong>While folic acid can help in the prevention of certain types of anemia, such as megaloblastic anemia, it is not the primary preventive measure for anemia during pregnancy, which is more commonly addressed with iron supplementation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Preeclampsia: </strong>Preeclampsia is a pregnancy complication characterized by high blood pressure and damage to other organ systems. There is no strong evidence that folic acid supplementation alone can prevent preeclampsia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Gestational diabetes: </strong>Gestational diabetes is a type of diabetes that develops during pregnancy. Folic acid supplementation is not known to prevent gestational diabetes; its primary preventive role is in reducing the risk of neural tube defects.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Folic acid supplementation before and during early pregnancy is essential to prevent neural tube defects in the developing fetus.</span></span></p>",
      "correct_choice_id": 221115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73088,
      "choices": [
        {
          "id": 291317,
          "text": "<p><span style=\"font-size:12.0pt;\">RBCs</span></p>"
        },
        {
          "id": 291318,
          "text": "<p><span style=\"font-size:12.0pt;\">Myoglobin</span></p>"
        },
        {
          "id": 291319,
          "text": "<p><span style=\"font-size:12.0pt;\">Creatine kinase</span></p>"
        },
        {
          "id": 291320,
          "text": "<p><span style=\"font-size:16px;\">Bilirubin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old electrical worker is brought to the emergency department after sustaining a high-voltage electric shock at work. He reports muscle pain, weakness, and dark-colored urine since the incident. Physical examination reveals tender, swollen muscles in the upper limbs. What is the most likely substance found in his urine? (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DmfYsp7.png\" width=\"303\" height=\"354\"></span></p>",
      "unique_key": "Q9575542",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833481,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B)</strong> <strong>Myoglobin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This patient presents with <strong>rhabdomyolysis</strong> following a high-voltage <strong>electrical injury</strong>, characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Muscle pain, weakness, and dark-colored urine (myoglobinuria)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Elevated creatine kinase (CK) levels</strong></span></li><li><span style=\"font-size:16px;\"><strong>Tender, swollen muscles</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Myoglobin</strong> is released into circulation from <strong>damaged muscle cells</strong> and subsequently filtered by the kidneys, leading to <strong>myoglobinuria</strong>, which can cause <strong>acute kidney injury (AKI)</strong> due to tubular toxicity and obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. RBCs:</strong> Would indicate <strong>hematuria</strong>, which is not the main feature of rhabdomyolysis</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Creatine kinase</strong>: Although CK levels are <strong>elevated</strong>, <strong>CK is not excreted in urine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Bilirubin:</strong> Suggests <strong>liver dysfunction or hemolysis</strong>, not <strong>muscle breakdown</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In rhabdomyolysis, myoglobin is released from damaged muscles, leading to myoglobinuria and a risk of acute kidney injury.</span></p>",
      "correct_choice_id": 291318,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73088/FMGE_Jan_2025_Medicine_Q_-_26.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73088/FMGE_Jan_2025_Medicine_Q_-_26.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73087,
      "choices": [
        {
          "id": 291313,
          "text": "<p><span style=\"font-size:12.0pt;\">HRZE (Isoniazid, Rifampin, Pyrazinamide, Ethambutol)</span></p>"
        },
        {
          "id": 291314,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone plus acyclovir</span></p>"
        },
        {
          "id": 291315,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone plus vancomycin</span></p>"
        },
        {
          "id": 291316,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefotaxime plus ampicillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with an intense headache, repeated vomiting, and neck stiffness. Lumbar puncture yields turbid cerebrospinal fluid (CSF). Microscopic analysis shows 90% polymorphonuclear leukocytes, a CSF glucose of 40 mg/dL (serum glucose: 120 mg/dL), and a protein concentration of 200 mg/dL. What is the most suitable treatment approach for this patient? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q4458727",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833480,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Ceftriaxone plus vancomycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The <strong>clinical presentation and CSF findings</strong> strongly suggest <strong>bacterial meningitis</strong>, characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Headache, vomiting, neck stiffness</strong> (classic triad)</span></li><li><span style=\"font-size:16px;\"><strong>Turbid CSF with neutrophilic pleocytosis (90% PMNs)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Low CSF glucose (&lt;50% of serum glucose)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Elevated protein (&gt;45 mg/dL)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Empirical treatment for adult bacterial meningitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Ceftriaxone</strong> – Covers <strong>Neisseria meningitidis and most pneumococci</strong></span></li><li><span style=\"font-size:16px;\"><strong>Vancomycin</strong> – Added to <strong>cover resistant Streptococcus pneumoniae</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. HRZE (anti-TB therapy):</strong> Used for <strong>tuberculous meningitis</strong>, which presents with <strong>chronic symptoms and lymphocytic pleocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Ceftriaxone + acyclovir:</strong> Used for <strong>HSV encephalitis</strong>, which shows <strong>lymphocytic pleocytosis and temporal lobe involvement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Cefotaxime + ampicillin</strong>: Used in <strong>neonatal, elderly, or immunocompromised patients</strong> (for <strong>Listeria monocytogenes</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Bacterial meningitis treatment involves empiric ceftriaxone + vancomycin to cover resistant pneumococci and meningococci.</span></p>",
      "correct_choice_id": 291315,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73087/FMGE_Jan_2025_Medicine_Q_-_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73087/FMGE_Jan_2025_Medicine_Q_-_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47664,
      "choices": [
        {
          "id": 190267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine</span></span></span></span></p>"
        },
        {
          "id": 190268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral Labetalol</span></span></span></span></p>"
        },
        {
          "id": 190269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV Labetalol</span></span></span></span></p>"
        },
        {
          "id": 190270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ramipril</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant female who is a known case of bronchial asthma presented to the hospital with blood pressure of 210/110 mm Hg. Which of the following is the preferred drug for this patient?</span></span></p>",
      "unique_key": "Q2935686",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833488,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Nifedipine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In managing hypertension in a pregnant patient with a history of bronchial asthma, the choice of antihypertensive medication is critical due to the contraindications of certain drug classes in both pregnancy and asthma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a calcium channel blocker that is considered safe in pregnancy and does not cause bronchoconstriction, making it the preferred choice for hypertensive management in a pregnant patient with asthma. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicardipine,&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">another calcium channel blocker, can also be used, especially in IV form, but nifedipine is often chosen due to its safety profile and efficacy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Oral Labetalol&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>Option C. IV Labetalol</strong>: Contraindicated in asthma due to bronchoconstriction. These drugs can exacerbate bronchial asthma by causing bronchoconstriction, making them unsuitable for patients with asthma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ramipril</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ACE inhibitors like Ramipril are contraindicated in pregnancy due to their association with fetal toxicity, including renal damage and oligohydramnios </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For hypertensive management in a pregnant patient with bronchial asthma, nifedipine is the preferred drug due to its safety in pregnancy and lack of bronchoconstrictive effects.</span></span></span></span></p>",
      "correct_choice_id": 190267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84351,
      "choices": [
        {
          "id": 335976,
          "text": "<p>Hyaline cast</p>"
        },
        {
          "id": 335977,
          "text": "<p>Coarse granular cast</p>"
        },
        {
          "id": 335978,
          "text": "<p>Broad waxy cast</p>"
        },
        {
          "id": 335979,
          "text": "<p>Epithelial cast</p>"
        }
      ],
      "text": "<p>Which of the following is most indicative of chronic renal failure? (NEET PG 2015)</p>",
      "unique_key": "Q9812218",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833259,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: C. Broad waxy cast.</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Broad waxy casts are characteristic findings in chronic kidney disease/chronic renal failure. These casts appear in the urine sediment when there is severe, long-standing tubular damage and reduced urine flow. Waxy casts are homogeneous, have a low refractive index, and often display cracked or broken edges, resembling candle wax. Their presence indicates significant tubular atrophy and interstitial fibrosis, hallmarks of chronic kidney disease.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Hyaline cast</strong>: Hyaline casts are composed primarily of Tamm-Horsfall mucoprotein and can be found in normal urine, especially after exercise. They may also appear with mild tubular dysfunction, dehydration, or concentrated urine, but are not specific for chronic renal failure.<br><br>&nbsp;</p><p><strong>Option B. Coarse granular cast</strong>: Coarse granular casts contain degenerating cellular debris and typically indicate active kidney injury. They are seen in acute tubular necrosis and other acute kidney injuries rather than chronic disease.<br><br>&nbsp;</p><p><strong>Option D. Epithelial cast</strong>: Epithelial casts contain shed renal tubular epithelial cells and indicate acute tubular damage. They are found in conditions such as acute tubular necrosis, viral infections affecting the kidney, or drug toxicity, not chronic renal failure.<br><br>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Broad waxy casts in urinary sediment are pathognomonic for chronic kidney disease and represent advanced, long-standing tubular damage and significantly reduced urinary flow.</p>",
      "correct_choice_id": 335978,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55412,
      "choices": [
        {
          "id": 221109,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Factor X inhibitor</span></span></p>"
        },
        {
          "id": 221110,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Direct Thrombin inhibitor</span></span></p>"
        },
        {
          "id": 221111,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increased ATIII activity</span></span></p>"
        },
        {
          "id": 221112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vitamin K inhibition</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What is the mechanism of action of Rivaroxaban? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q3039882",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833280,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Factor X inhibitor</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rivaroxaban is an oral anticoagulant that functions as a direct Factor Xa inhibitor. Factor Xa plays a crucial role in the coagulation cascade, leading to the conversion of prothrombin to thrombin, which subsequently forms fibrin clots. By inhibiting Factor Xa, Rivaroxaban effectively prevents the formation of thrombin and subsequent clot formation, providing anticoagulant effects.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Direct Thrombin inhibitor:</strong> Drugs that act as direct thrombin inhibitors include Dabigatran, Argatroban, Bivalirudin, and Lepirudin. These drugs directly inhibit thrombin, preventing the conversion of fibrinogen to fibrin.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Increased ATIII activity:</strong> This mechanism is associated with heparins and heparinoids. These drugs enhance the activity of antithrombin III (ATIII), which inactivates thrombin and other proteases involved in blood clotting.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Vitamin K inhibition:</strong> Warfarin and other coumarin derivatives inhibit the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X) by inhibiting vitamin K epoxide reductase. This reduces the body&#39;s ability to form clots.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rivaroxaban is a direct Factor Xa inhibitor, which prevents the formation of thrombin and subsequent clot formation in the coagulation cascade.</span></span></p>",
      "correct_choice_id": 221109,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47651,
      "choices": [
        {
          "id": 190215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FISH</span></span></span></span></p>"
        },
        {
          "id": 190216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone marrow Aspiration</span></span></span></span></p>"
        },
        {
          "id": 190217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAP score</span></span></span></span></p>"
        },
        {
          "id": 190218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotyping</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is used as a diagnostic test for CML? (</span></span></span></span>FMGE Jan 2024)</p>",
      "unique_key": "Q6878180",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833274,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) FISH</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluorescent In-Situ Hybridization (FISH) is the gold standard for diagnosing Chronic Myeloid Leukemia (CML).&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test detects the presence of the Philadelphia chromosome, which is the result of a translocation between chromosomes 9 and 22, creating the BCR-ABL fusion gene. This fusion gene produces a protein with abnormal tyrosine kinase activity, which drives the pathogenesis of CML.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bone marrow Aspiration</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it can show increased cellularity and myeloid hyperplasia, i.e. help in assessing the extent of disease and marrow involvement but is not definitive for diagnosing CML.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. LAP score</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Low in CML but also low in other conditions, hence not specific.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Karyotyping</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it can detect chromosomal abnormalities, it is less sensitive compared to FISH for detecting the BCR-ABL fusion gene.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluorescent In-Situ Hybridization (FISH) is the gold standard diagnostic test for Chronic Myeloid Leukemia (CML) because it specifically identifies the BCR-ABL fusion gene.</span></span></span></span></p>",
      "correct_choice_id": 190215,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55417,
      "choices": [
        {
          "id": 221129,
          "text": "<p><span style=\"font-size:18px;\">Splenic rupture</span></p>"
        },
        {
          "id": 221130,
          "text": "<p><span style=\"font-size:18px;\">Thrombocytopenia</span></p>"
        },
        {
          "id": 221131,
          "text": "<p><span style=\"font-size:18px;\">Hairy cell leukemia</span></p>"
        },
        {
          "id": 221132,
          "text": "<p><span style=\"font-size:18px;\">Bone marrow failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Splenectomy is contraindicated in which of the following conditions? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7483548",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833491,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Bone marrow failure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Bone marrow failure</strong> often seen in aplastic anemia, involves the failure of the bone marrow to produce sufficient blood cells. The spleen is not involved in this pathology, so splenectomy would not be beneficial. The problem lies within the bone marrow, not the spleen, making splenectomy contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Splenic rupture:</strong> Splenectomy is commonly indicated in cases of splenic rupture, whether due to trauma or iatrogenic causes, to prevent life-threatening hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Thrombocytopenia:</strong> In cases of idiopathic thrombocytopenic purpura (ITP), splenectomy can be an effective treatment option to achieve durable remission, although it is not the first-line treatment.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Corticosteroids and other treatments are often tried first.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Hairy cell leukemia:</strong> Splenectomy may be indicated in hairy cell leukemia in cases of massive splenomegaly or persistent cytopenias to alleviate symptoms and improve blood counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Splenectomy is contraindicated in bone marrow failure, as the underlying issue resides in the bone marrow's inability to produce blood cells.</span></p>",
      "correct_choice_id": 221132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92173,
      "choices": [
        {
          "id": 367008,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 367009,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous immunoglobulin (IVIG)</span></p>"
        },
        {
          "id": 367010,
          "text": "<p><span style=\"font-size:14.0pt;\">Bone Marrow Transplant</span></p>"
        },
        {
          "id": 367011,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A young boy presents with a platelet count of 10,000/μL. Bone marrow aspirate reveals normal cellularity with increased number of megakaryocytes. What is the most appropriate initial treatment for this condition? (INICET MAY 2025)</span></p>",
      "unique_key": "Q6114677",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833250,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intravenous immunoglobulin (IVIG)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This clinical presentation is consistent with immune thrombocytopenic purpura (ITP). The key features include severe thrombocytopenia (platelet count 10,000/μL), normal bone marrow cellularity with increased megakaryocytes, indicating peripheral platelet destruction rather than production failure. In patients with life-threatening thrombocytopenia or severe bleeding in ITP, intravenous immunoglobulin (IVIG) is the first-line treatment. IVIG works by blocking or saturating macrophage Fc receptors, providing faster response (24-48 hours) compared to corticosteroids. In non-bleeding patients without urgent symptoms, corticosteroids would be the first-line treatment, but given the severely low platelet count, IVIG is more appropriate for immediate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Methotrexate:</strong> This immunosuppressive agent is not used in the initial treatment of ITP. It may be considered as a second-line or third-line agent in refractory cases, but it is not appropriate for initial management, especially in a young patient with severe thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bone Marrow Transplant:</strong> This is not indicated in ITP since the condition involves peripheral destruction of platelets rather than bone marrow failure. The bone marrow is functioning normally with increased megakaryocyte production, making transplantation unnecessary and inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Aspirin:</strong> This would be contraindicated in a patient with severe thrombocytopenia as it would further impair platelet function and significantly increase bleeding risk. Aspirin inhibits platelet aggregation, which would be dangerous in someone with already critically low platelet counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In ITP with severe thrombocytopenia and bleeding risk, IVIG provides rapid response by blocking macrophage Fc receptors and is the preferred initial treatment.</span></p>",
      "correct_choice_id": 367009,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92173/INI_CET_May_2025_Medicine_Q_-_29.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92173/INI_CET_May_2025_Medicine_Q_-_29.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74909,
      "choices": [
        {
          "id": 298533,
          "text": "<p><span style=\"font-size:16px;\">Vitamin B12 deficiency</span></p>"
        },
        {
          "id": 298534,
          "text": "<p><span style=\"font-size:16px;\">Vitamin B6 deficiency</span></p>"
        },
        {
          "id": 298535,
          "text": "<p><span style=\"font-size:16px;\">Thiamine deficiency</span></p>"
        },
        {
          "id": 298536,
          "text": "<p><span style=\"font-size:16px;\">Folic acid deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient complained of bilateral lower limb numbness. He has a history of low BP and gastrectomy done for gastric cancer a year back. On examination, Romberg test is positive and there is loss of proprioception in both lower limbs. Which of the following deficiency can cause this condition? (INICET NOV 2024)</span></p>",
      "unique_key": "Q2222365",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833254,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Vitamin B12 deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This patient's presentation strongly suggests Vitamin B12 deficiency for several reasons:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>History of gastrectomy</strong> – Loss of stomach leads to loss of intrinsic factor, essential for B12 absorption</span></li><li><span style=\"font-size:16px;\"><strong>Neurological symptoms</strong> – Bilateral lower limb numbness</span></li><li><span style=\"font-size:16px;\"><strong>Positive Romberg test and loss of proprioception</strong> indicate posterior column involvement, which is characteristic of subacute combined degeneration of the spinal cord seen in B12 deficiency</span></li><li><span style=\"font-size:16px;\">The combination of gastrectomy and neurological symptoms is classic for B12 deficiency</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Vitamin B6 deficiency:</strong> While it can cause peripheral neuropathy, it doesn't typically cause posterior column signs</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Thiamine deficiency:</strong> Primarily causes Wernicke's encephalopathy and cardiovascular symptoms; doesn't typically present with proprioception loss; more commonly seen in alcoholics</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Folic acid deficiency:</strong> Primarily causes hematological manifestations; does not cause neurological symptoms like B12 deficiency</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Gastrectomy leads to B12 deficiency due to loss of intrinsic factor, and B12 deficiency can cause subacute combined degeneration of the spinal cord, presenting with posterior column signs (proprioception loss and positive Romberg test).</span></p>",
      "correct_choice_id": 298533,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74909/INI-CET_NOV_2024_Medicine_Q_-_34.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74909/INI-CET_NOV_2024_Medicine_Q_-_34.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74910,
      "choices": [
        {
          "id": 298537,
          "text": "<p><span style=\"font-size:16px;\">Protein C deficiency</span></p>"
        },
        {
          "id": 298538,
          "text": "<p><span style=\"font-size:16px;\">PNH (Paroxysmal Nocturnal Hemoglobinuria)</span></p>"
        },
        {
          "id": 298539,
          "text": "<p><span style=\"font-size:16px;\">Factor V Leiden mutation</span></p>"
        },
        {
          "id": 298540,
          "text": "<p><span style=\"font-size:16px;\">Antithrombin III deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">All are hereditary causes of thrombosis except: (INICET NOV 2024)</span></p>",
      "unique_key": "Q9705947",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833255,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) PNH (Paroxysmal Nocturnal Hemoglobinuria)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PNH is an <strong>acquired</strong> stem cell disorder, not a hereditary condition. It occurs due to a <strong>somatic mutation in the PIG-A gene</strong> that produces GPI (glycosyl phosphatidylinositol) anchors. This defect affects proteins <strong>CD55 and CD59</strong> (also known as DAF and MIRL respectively), which are important complement regulatory proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;A. Protein C deficiency:</strong> Hereditary cause of thrombosis; Protein C is a natural anticoagulant</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C.</strong> <strong>Factor V Leiden mutation:&nbsp;</strong>Most common inherited cause of thrombophilia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.</strong> <strong>Antithrombin III deficiency:&nbsp;</strong>Inherited condition increasing thrombotic risk</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PNH is an <strong>acquired</strong> (not hereditary) stem cell disorder caused by somatic mutations in the PIG-A gene. Protein C deficiency, Factor V Leiden mutation, and Antithrombin III deficiency are <strong>hereditary</strong> causes of thrombophilia.</span></p>",
      "correct_choice_id": 298538,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74910/INI-CET_NOV_2024_Medicine_Q_-_35.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74910/INI-CET_NOV_2024_Medicine_Q_-_35.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47653,
      "choices": [
        {
          "id": 190223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></span></span></span></p>"
        },
        {
          "id": 190224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine</span></span></span></span></p>"
        },
        {
          "id": 190225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></span></p>"
        },
        {
          "id": 190226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ivabradine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with Ventricular Tachycardia. What is the best drug?</span></span></span></span></p>",
      "unique_key": "Q3354497",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833276,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Amiodarone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For treating ventricular tachycardia (VT), the drug of choice in acute situations according to Advanced Life Support (ALS) protocols is Amiodarone. It is a class III antiarrhythmic medication that works by prolonging the action potential duration and refractory period in the myocardial cells, thus stabilizing the cardiac rhythm.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Adenosine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ineffective for ventricular tachycardia as it is primarily used for supraventricular tachycardia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Propranolol</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A beta-blocker used for various cardiac conditions, but not typically effective for acute VT.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ivabradine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Used to reduce heart rate in chronic heart failure and stable angina, not suitable for VT management</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone is the best drug for the acute management of ventricular tachycardia due to its efficacy in stabilizing cardiac rhythm by prolonging the action potential and refractory period in myocardial cells.</span></span></span></span></p>",
      "correct_choice_id": 190223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55411,
      "choices": [
        {
          "id": 221105,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">AB negative</span></span></p>"
        },
        {
          "id": 221106,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B</span></span></p>"
        },
        {
          "id": 221107,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oh</span></span></p>"
        },
        {
          "id": 221108,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">O negative</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What blood group can be transfused to an individual with Bombay blood group? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q6183537",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833279,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Oh</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The Bombay blood group, also known as the Oh blood group, is a rare blood type that lacks the H antigen, which is present in all other blood types. Individuals with the Bombay blood group have antibodies against the H antigen, which means they cannot receive blood from any of the common ABO blood groups, including the universal donor O blood group, as it contains the H antigen. Transfusing blood that contains the H antigen to someone with the Bombay blood group would lead to a severe hemolytic reaction. Therefore, individuals with the Bombay blood group can only receive blood from other Bombay blood group donors.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. AB negative:</strong> This blood group contains the H antigen and would cause a hemolytic reaction in a Bombay blood group individual.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. B:</strong> This blood group also contains the H antigen, making it incompatible with the Bombay blood group.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. O negative:</strong> Although O negative is considered a universal donor in the context of the ABO and Rh systems, it still contains the H antigen and is therefore not compatible with the Bombay blood group.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Individuals with the Bombay blood group (Oh) can only receive blood from other Bombay blood group donors due to the presence of anti-H antibodies.</span></span></p>",
      "correct_choice_id": 221107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59467,
      "choices": [
        {
          "id": 237181,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Doppler echocardiography</span></span></span></p>"
        },
        {
          "id": 237182,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CT pulmonary angiography</span></span></span></p>"
        },
        {
          "id": 237183,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventilation perfusion scan of lungs</span></span></span></p>"
        },
        {
          "id": 237184,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MR pulmonary angiography</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A resident is evaluating a patient, who presented with acute onset of chest pain and dyspnea, for pulmonary embolism. Which of the following imaging test should be performed to confirm this diagnosis? (FMGE DEC 2021)</span></span></p>",
      "unique_key": "Q6350893",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833267,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) CT pulmonary angiography</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CT pulmonary angiography is the gold standard imaging test for diagnosing pulmonary embolism, providing detailed images of the pulmonary arteries. It is highly sensitive and specific for detecting emboli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - D-dimer test is used as an initial screening tool. Elevated levels of D-dimer can suggest the presence of a thrombus, but it is not specific and can be elevated in various other conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Doppler echocardiography:</span></strong><span style=\"font-size:12.0pt\"> Can show right heart strain but is not definitive for diagnosing PE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ventilation perfusion scan of lungs:</span></strong><span style=\"font-size:12.0pt\"> Used when CT angiography is contraindicated but less specific.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. MR pulmonary angiography:</span></strong><span style=\"font-size:12.0pt\"> Less commonly used and not the first-line diagnostic tool.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CT pulmonary angiography is the gold standard for diagnosing pulmonary embolism.</span></span></span></p>",
      "correct_choice_id": 237182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74906,
      "choices": [
        {
          "id": 298521,
          "text": "<p><span style=\"font-size:16px;\">Decreased action of LPL and increased action of HSL</span></p>"
        },
        {
          "id": 298522,
          "text": "<p><span style=\"font-size:16px;\">Increased action of LPL and increased action of HSL</span></p>"
        },
        {
          "id": 298523,
          "text": "<p><span style=\"font-size:16px;\">Decreased action of LPL and decreased action of HSL</span></p>"
        },
        {
          "id": 298524,
          "text": "<p><span style=\"font-size:16px;\">Increased action of LPL and decreased action of HSL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In a patient with diabetes mellitus, the synthesis of TG and VLDL is increased from the liver. What is the cause of the same? (INICET NOV 2024)</span></p>",
      "unique_key": "Q8475908",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833251,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Decreased action of LPL and increased action of HSL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In diabetes mellitus, insulin deficiency or resistance leads to two important enzymatic changes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Decreased activity of Lipoprotein Lipase (LPL)</strong> – This enzyme normally converts triglycerides in blood to free fatty acids for storage in adipose tissue</span></li><li><span style=\"font-size:16px;\"><strong>Increased activity of Hormone Sensitive Lipase (HSL)</strong> – This promotes release of stored triglycerides as free fatty acids from adipose tissue</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">These changes result in:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Increased triglycerides in blood due to decreased LPL activity</span></li><li><span style=\"font-size:16px;\">Increased lipolysis and ketosis due to increased HSL activity</span></li><li><span style=\"font-size:16px;\">Overall increase in circulating free fatty acids</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Increased action of LPL and increased action of HSL:</strong> Insulin resistance/deficiency <strong>decreases</strong> LPL activity</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Decreased action of LPL and decreased action of HSL:</strong> HSL activity is <strong>increased</strong>, not decreased in diabetes</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Increased action of LPL and decreased action of HSL:</strong> This would increase TG clearance and decrease lipolysis, opposite to what occurs in diabetes</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In diabetes mellitus, decreased LPL and increased HSL activities lead to increased triglycerides and VLDL synthesis in the liver, contributing to diabetic dyslipidemia.</span></p>",
      "correct_choice_id": 298521,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74906/INI-CET_NOV_2024_Medicine_Q_-_31.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74906/INI-CET_NOV_2024_Medicine_Q_-_31.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47655,
      "choices": [
        {
          "id": 190231,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Epinephrine</span></p>"
        },
        {
          "id": 190232,
          "text": "<p><span style=\"font-size:12.0pt;\">20% IV Intralipid</span></p>"
        },
        {
          "id": 190233,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Soda Bicarbonate</span></p>"
        },
        {
          "id": 190234,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Dobutamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was given 0.5% bupivacaine for supraclavicular brachial plexus block and suddenly developed hypotension and arrhythmias. Which of the following is the first line of management? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">FMGE Jan 2024)</span></p>",
      "unique_key": "Q9610011",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833486,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 20% IV Intralipid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient experienced toxicity due to bupivacaine, a local anesthetic. The first-line treatment for local anesthetic toxicity, including bupivacaine toxicity, is the administration of 20% IV intralipid (lipid emulsion therapy). This treatment works by acting as a \"lipid sink,\" which helps to absorb the lipophilic local anesthetic molecules and reduce their toxic effects on the cardiovascular and central nervous systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. IV Epinephrine</strong>: Suitable for cardiac arrest but not the first line for local anesthetic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV Soda Bicarbonate</strong>: Used in cases of tricyclic antidepressant (TCA) toxicity causing ventricular arrhythmias but not for local anesthetic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IV Dobutamine</strong>: Used to treat heart failure and certain types of shock, but not specifically for local anesthetic toxicity</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first-line treatment for bupivacaine toxicity is the administration of 20% IV intralipid (lipid emulsion therapy).</span></p>",
      "correct_choice_id": 190232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11224,
      "choices": [
        {
          "id": 44862,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takotsubo cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 44863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 44864,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brugada cardiomyopathy</span></span></span></span></p>"
        },
        {
          "id": 44865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pericardial tamponade</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The observed myocardial stunning pattern does not match the ECG findings of a patient. What is the probable diagnosis?</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q5592640",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833264,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Takotsubo cardiomyopathy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm19.jpg\" style=\"height:277px; width:500px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress cardiomyopathy commonly affects <strong>Women (post-menopausal) &gt; men </strong>predominantly due to <strong>emotional &gt; physical stress</strong>. Neurogenic myocardial stunning occurs leading to heart failure. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 (Gs stimulation) is present at base and b2 (Gi) activation leads to <strong>hypercontractility at the base &amp; apical ballooning</strong> giving a typical Takotsubo appearance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECG mimics ACS</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, RWMA not corresponding to single artery territory, normal CAG with Mild troponin elevation are clues to takotsubo.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with beta-blockers, ACE inhibitors if non-responsive. Carries good prognosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive cardiomyopathy causes diastolic dysfunction on but <strong>NOT significant ECG changes.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brugada syndrome is a channelopathy caused <strong>due LOF (loss of function) mutation of cardiac SCN5a (Sodium channel)</strong> resulting in transmural voltage difference between endocardium-epicardium causing ventricular arrhythmias which initially affects the RV myocardium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm20.jpg\" style=\"height:205px; width:500px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamponade occurs due to rapid accumulation of fluid/blood in the pericardium producing the characteristic&nbsp;</span></span><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beck triad (&uarr;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JVP </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&darr; </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart sounds </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&darr; </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP).</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takotsubo cardiomyopathy should be considered when a patient&#39;s clinical presentation includes myocardial stunning that does not correspond to ECG findings typical of a myocardial infarction, especially in the context of recent significant emotional or physical stress.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Cardiology/Cardiomyopathies/Chap 259</span></span></strong></p>",
      "correct_choice_id": 44862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47648,
      "choices": [
        {
          "id": 190203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XXY</span></span></span></span></p>"
        },
        {
          "id": 190204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45XX</span></span></span></span></p>"
        },
        {
          "id": 190205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45X0</span></span></span></span></p>"
        },
        {
          "id": 190206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XY</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A dwarf female patient brought to the hospital with a history of primary amenorrhea, webbed neck, and widely placed nipples. What is the most common karyotype associated with this condition?</span></span></p>",
      "unique_key": "Q1491022",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833271,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 45X0</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presentation of a dwarf female patient with primary amenorrhea, webbed neck, and widely spaced nipples is characteristic of Turner syndrome. Turner syndrome is a chromosomal disorder caused by complete or partial monosomy of the X chromosome, most commonly represented by the karyotype 45X0. This syndrome is the most common cause of primary amenorrhea.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner syndrome, characterized by the karyotype 45X0, is the most common chromosomal disorder associated with features such as primary amenorrhea, webbed neck, and widely spaced nipples in females.</span></span></span></span></p>",
      "correct_choice_id": 190205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74908,
      "choices": [
        {
          "id": 298529,
          "text": "<p><span style=\"font-size:16px;\">Nuclear pattern; SLE</span></p>"
        },
        {
          "id": 298530,
          "text": "<p><span style=\"font-size:16px;\">Homogeneous pattern; SLE</span></p>"
        },
        {
          "id": 298531,
          "text": "<p><span style=\"font-size:16px;\">Speckled pattern; Systemic sclerosis</span></p>"
        },
        {
          "id": 298532,
          "text": "<p><span style=\"font-size:16px;\">Anti-centromere pattern; Systemic sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient presented with recurrent Raynaud’s phenomenon. She also complained of thickening of skin in the hands and difficulty in swallowing. What is the diagnosis and immunofluorescence pattern shown? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xOrfzxr.png\" width=\"383\" height=\"381\"></span></p>",
      "unique_key": "Q5245863",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833253,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Anti-centromere pattern; Systemic sclerosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The combination of Raynaud's phenomenon, skin thickening limited to hands (acral areas), and difficulty swallowing points to <strong>limited systemic sclerosis</strong> (formerly called CREST syndrome). The immunofluorescence image shows a characteristic <strong>centromeric pattern</strong> with discrete speckles corresponding to centromeres in dividing cells. Anti-centromere antibodies are specifically associated with <strong>limited systemic sclerosis</strong>, making this pattern diagnostic in this clinical context.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Nuclear pattern; SLE:</strong> Incorrect. The pattern shown is centromeric, not nuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Homogeneous pattern; SLE</strong>: Incorrect. Homogeneous patterns are produced by anti-histone and anti-dsDNA antibodies, seen in SLE or drug-induced lupus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Speckled pattern; Systemic sclerosis:</strong> Incorrect. While speckled patterns can be seen in systemic sclerosis (particularly with anti-Scl-70 antibodies in diffuse disease), the image shows a <strong>centromeric</strong> pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Anti-centromere antibodies producing a centromeric immunofluorescence pattern are specifically associated with <strong>limited systemic sclerosis</strong>, particularly when presenting with Raynaud's phenomenon and acral skin thickening.</span></p>",
      "correct_choice_id": 298532,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74908/INI-CET_NOV_2024_Medicine_Q_-_33.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74908/INI-CET_NOV_2024_Medicine_Q_-_33.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84313,
      "choices": [
        {
          "id": 335828,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-Polio Syndrome</span></p>"
        },
        {
          "id": 335829,
          "text": "<p><span style=\"font-size:12.0pt;\">Polymyositis</span></p>"
        },
        {
          "id": 335830,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscular Dystrophy</span></p>"
        },
        {
          "id": 335831,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuropathy</span></p>"
        }
      ],
      "text": "<p>A 45-year-old woman visits the outpatient clinic complaining of pain, fatigue, and weakness in both lower limbs. She reports a history of childhood paralysis affecting both lower limbs, from which she had a good functional recovery. Which of the following is the most likely diagnosis? (NEET PG 2016)</p>",
      "unique_key": "Q2278696",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833483,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Post-Polio Syndrome</strong></p><p>&nbsp;</p><p>Post-Polio Syndrome (PPS) is characterized by new weakness, fatigue, and pain that develops decades after an initial episode of paralytic poliomyelitis from which the patient had at least partial recovery. The patient's history of childhood paralysis affecting both lower limbs with good functional recovery, followed by new symptoms of pain, fatigue, and weakness in the same distribution decades later (now at age 45) is the classic presentation of PPS.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Polymyositis</strong>: Polymyositis typically presents with subacute onset of symmetric proximal muscle weakness without a prior history of paralysis. It does not follow a pattern of recurrence after decades of stability. The inflammatory myopathies like polymyositis are characterized by elevated muscle enzymes, characteristic EMG findings, and muscle biopsy showing inflammation, which are not mentioned in this case. The history of childhood paralysis with good recovery followed by late deterioration is not consistent with polymyositis.</p><p>&nbsp;</p><p><strong>Option C. Muscular Dystrophy</strong>: Muscular dystrophies are inherited disorders with progressive weakness that typically begins in childhood or early adulthood. They do not present with an episode of paralysis followed by recovery and then delayed deterioration decades later. Most muscular dystrophies show a pattern of continuous progression rather than the biphasic course described in this patient.</p><p>&nbsp;</p><p><strong>Option D. Neuropathy</strong>: Peripheral neuropathies typically present with distal weakness, sensory symptoms, and often absent reflexes. While some neuropathies can affect the lower limbs predominantly, the history of childhood paralysis with recovery followed by late deterioration is not characteristic of most neuropathies. Additionally, neuropathies often have sensory symptoms which aren't prominent in this case.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Post-polio syndrome presents as new weakness, fatigue, and pain occurring decades after recovery from acute paralytic poliomyelitis, typically affecting the same muscle groups that were originally involved.</p>",
      "correct_choice_id": 335828,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84312,
      "choices": [
        {
          "id": 335824,
          "text": "<p><span style=\"font-size:12.0pt;\">Friedreich’s Ataxia</span></p>"
        },
        {
          "id": 335825,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute Combined Degeneration of the Spinal Cord</span></p>"
        },
        {
          "id": 335826,
          "text": "<p><span style=\"font-size:12.0pt;\">Becker's Muscular Dystrophy</span></p>"
        },
        {
          "id": 335827,
          "text": "<p><span style=\"font-size:12.0pt;\">Tabes Dorsalis</span></p>"
        }
      ],
      "text": "<p>A 12-year-old boy arrives at the outpatient clinic with a history of progressively worsening difficulty in walking and frequent episodes of falling. Physical examination shows an ataxic gait with absent deep tendon reflexes. The Babinski sign is negative, and the plantar reflex demonstrates an extensor response. Which diagnosis is most likely? (NEET PG 2016)</p>",
      "unique_key": "Q8632442",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833262,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Friedreich's Ataxia</strong></p><p>&nbsp;</p><p>Friedreich's ataxia is characterized by progressive cerebellar ataxia, absent deep tendon reflexes, and pyramidal signs. The clinical presentation of a 12-year-old boy with progressively worsening gait difficulty, ataxia, and absent deep tendon reflexes strongly suggests this diagnosis. Friedreich's ataxia typically presents in childhood or adolescence (before age 25) and affects the posterior columns, spinocerebellar tracts, and corticospinal tracts, leading to the combination of sensory ataxia and pyramidal signs. The loss of deep tendon reflexes reflects peripheral sensory neuronopathy, while extensor plantar responses indicate corticospinal tract involvement.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option Subacute Combined Degeneration</strong>: While this also affects posterior columns and corticospinal tracts, it's caused by vitamin B12 deficiency and typically presents in adults. It would show increased, not absent, deep tendon reflexes.</p><p>&nbsp;</p><p><strong>Option Becker's Muscular Dystrophy</strong>: This dystrophinopathy presents with proximal muscle weakness rather than ataxia. Reflexes would be preserved until late in the disease, and there would be no sensory involvement or extensor plantar responses.</p><p>&nbsp;</p><p><strong>Option Tabes Dorsalis</strong>: This manifestation of tertiary syphilis is extremely rare in children. While it causes sensory ataxia and areflexia, it lacks pyramidal signs (would not have extensor plantar responses) and would be highly unusual in a 12-year-old.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>The combination of progressive ataxia, absent deep tendon reflexes, and extensor plantar responses in an adolescent is the classic presentation of Friedreich's ataxia, reflecting the disease's characteristic involvement of multiple spinal cord pathways.</p>",
      "correct_choice_id": 335824,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47654,
      "choices": [
        {
          "id": 190227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B3</span></span></span></span></p>"
        },
        {
          "id": 190228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B1</span></span></span></span></p>"
        },
        {
          "id": 190229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D</span></span></span></span></p>"
        },
        {
          "id": 190230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin C</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A chronic alcoholic presented with pruritic eczematous rash on the neck and dorsum of hands. What is the likely nutritional deficiency?</span></span></p>",
      "unique_key": "Q4381434",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833485,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Vitamin B3</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic alcoholics are prone to multiple nutrient deficiencies due to malnourishment and malnutrition. The given history is compatible with a disease called Pellagra, which is due to Niacin (Vitamin B3) deficiency. Pellagra is characterized by the &quot;3 D&#39;s&quot;: Diarrhea, Dermatitis, and Dementia, and it can also lead to death, sometimes referred to as the &quot;4 D&#39;s.&quot;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Vitamin B1</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Causes Wernicke&#39;s encephalopathy, peripheral neuropathy, and heart failure but does not match the described skin condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vitamin D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Associated with rickets and osteomalacia, not pruritic eczematous rash.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vitamin C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Causes scurvy with gum bleeding and other symptoms, not the described dermatitis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pellagra, characterized by the &quot;3 D&#39;s&quot; (Diarrhea, Dermatitis, Dementia), is caused by Vitamin B3 (Niacin) deficiency and is commonly seen in chronic alcoholics.</span></span></span></span></p>",
      "correct_choice_id": 190227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59468,
      "choices": [
        {
          "id": 237185,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis</span></span></span></p>"
        },
        {
          "id": 237186,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enteropathic arthritis</span></span></span></p>"
        },
        {
          "id": 237187,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rheumatoid arthritis</span></span></span></p>"
        },
        {
          "id": 237188,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Psoriatic arthritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with severe pain and swelling in his knee joint for 10 days. He also complains of pain and discomfort during urination. He says that he had diarrhea one month ago and has been unwell since then. What is the most likely diagnosis? (FMGE DEC 2021)</span></span></p>",
      "unique_key": "Q6026601",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833544,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Reactive arthritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis typically follows a gastrointestinal or genitourinary infection and presents with arthritis, urethritis, and conjunctivitis (Reiter&#39;s syndrome). The patient&#39;s history of diarrhea one month ago and current symptoms of joint pain and urethritis are classic signs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reactive Arthritis</span></strong><span style=\"font-size:12.0pt\"> is a type of inflammatory arthritis that typically occurs following an infection. Here&rsquo;s a summary of its key points:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Common Triggers</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gastrointestinal Infections</span></strong><span style=\"font-size:12.0pt\">: Often caused by bacteria such as <em>Shigella</em>.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Genitourinary Infections</span></strong><span style=\"font-size:12.0pt\">: Most commonly associated with non-gonococcal urethritis, particularly due to <em>Chlamydia</em>.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Classic Triad of Symptoms</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Arthritis</span></strong><span style=\"font-size:12.0pt\">: Joint inflammation and pain.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Conjunctivitis</span></strong><span style=\"font-size:12.0pt\">: Eye inflammation.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Urethritis</span></strong><span style=\"font-size:12.0pt\">: Inflammation of the urethra.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mnemonic</span></strong><span style=\"font-size:12.0pt\">: The classic triad is summarized as &quot;Can&#39;t see, can&#39;t pee, can&#39;t climb a tree.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Enteropathic arthritis</span></strong><span style=\"font-size:12.0pt\">: Associated with inflammatory bowel diseases like Crohn&#39;s and UC, without preceding infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Rheumatoid arthritis</span></strong><span style=\"font-size:12.0pt\">: Chronic, symmetrical joint involvement, not typically post-infectious.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Psoriatic arthritis</span></strong><span style=\"font-size:12.0pt\">: Associated with psoriasis, not a preceding infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis follows gastrointestinal or genitourinary infections and presents with arthritis, urethritis, and sometimes conjunctivitis.</span></span></span></p>",
      "correct_choice_id": 237185,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55416,
      "choices": [
        {
          "id": 221125,
          "text": "<p><span style=\"font-size:12pt;\">Relative polycythemia</span></p>"
        },
        {
          "id": 221126,
          "text": "<p><span style=\"font-size:12pt;\">Absolute polycythemia</span></p>"
        },
        {
          "id": 221127,
          "text": "<p><span style=\"font-size:12pt;\">Severe internal bleeding</span></p>"
        },
        {
          "id": 221128,
          "text": "<p><span style=\"font-size:12pt;\">Myeloproliferative disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is Gaisböck syndrome? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7801289",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833490,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Relative polycythemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gaisböck syndrome, also known as stress polycythemia or pseudopolycythemia, is a condition characterized by an apparent increase in the red blood cell (RBC) mass due to a reduction in plasma volume, typically caused by dehydration. This leads to an elevated hematocrit and hemoglobin concentration without an actual increase in the total number of red blood cells. The condition is termed \"relative polycythemia\" because the increase in RBC concentration is relative to the decreased plasma volume rather than an absolute increase in RBC production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Absolute polycythemia:</strong> Absolute polycythemia refers to a true increase in the total red blood cell mass. This can occur due to primary polycythemia (polycythemia vera) or secondary polycythemia due to chronic hypoxia or erythropoietin-secreting tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Severe internal bleeding:</strong> Severe internal bleeding would typically lead to a decrease in RBC mass and hematocrit, not an increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Myeloproliferative disorder:</strong> Myeloproliferative disorders are a group of conditions that involve the overproduction of blood cells in the bone marrow, such as polycythemia vera. These disorders lead to absolute, not relative, polycythemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gaisböck syndrome is a form of relative polycythemia caused by a reduction in plasma volume, often due to dehydration, leading to an apparent increase in red blood cell concentration.</span></p>",
      "correct_choice_id": 221125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54295,
      "choices": [
        {
          "id": 216649,
          "text": "<p><span style=\"font-size:12.0pt;\">Triple Phosphate</span></p>"
        },
        {
          "id": 216650,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium oxalate</span></p>"
        },
        {
          "id": 216651,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystine</span></p>"
        },
        {
          "id": 216652,
          "text": "<p><span style=\"font-size:12.0pt;\">Uric acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the crystal in a patient with urinary pH of 8.7:</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-130550.jpg\" alt=\"\" width=\"400\" height=\"300\"></span></p>",
      "unique_key": "Q7118993",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833257,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Triple Phosphate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normally, urinary pH typically ranges from <strong>4.4 to 6.5</strong>, which is acidic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here, an alkaline urinary pH of 8.7 promotes the formation of certain types of crystals, particularly <strong>triple phosphate (struvite) and calcium phosphate crystals</strong>. The image provided shows typical <strong>\"coffin-lid\" shaped crystals</strong>, which are characteristic of triple phosphate (magnesium ammonium phosphate) or struvite crystals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Triple Phosphate</strong> crystals are commonly associated with urinary tract infections caused by urease-positive bacteria such as <i>Proteus</i>, <i>Klebsiella</i>, and <i>Ureaplasma urealyticum</i>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcium Oxalate :</strong> These crystals typically form in acidic urine and have different shapes, such as envelope or dumbbell shapes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cystine :</strong> These crystals also form in acidic urine and have a distinctive hexagonal shape.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Uric Acid :</strong> These crystals form in acidic urine and appear as rhomboid or rosette shapes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Triple phosphate (struvite) crystals are associated with alkaline urine and have a \"coffin-lid\" appearance. They are commonly seen in patients with urinary tract infections caused by urease-positive organisms.</span></p>",
      "correct_choice_id": 216649,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54295/INI-CET_May_2024Medicine_Question_40.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54295/INI-CET_May_2024Medicine_Question_40.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}